AURKB
Reaktivität: Human
IHC, StM
Wirt: Maus
Monoclonal
AURKB-1592
unconjugated
Applikationshinweise
Optimal dilution of the Aurora B antibody should be determined by the researcher.\. Western blot: 0.5-1 μg/mL,FACS: 0.5-1 μg/10e6 cells in 0.1ml,IF: 1-2 μg/mL
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
1 mg/mL
Buffer
1 mg/mL in 1X PBS, BSA free, sodium azide free
Konservierungsmittel
Azide free
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store the Aurora B antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Target
Aurora Kinase B (AURKB)
Andere Bezeichnung
Aurora B / AURKB
Hintergrund
Recognizes a protein of 39-45 kDa, which is identified as Aurora B. The serine/threonine protein kinase aurora B (Aurora B) is a chromosomal passenger protein critical for accurate chromosome segregation, cytokinesis, protein localization to the centromere and kinetochore, correct microtubule-kinetochore attachment, and regulation of the mitotic checkpoint. Aurora B forms a tight complex with inner centrosome protein and survivin. Inactivation of any of these proteins causes similar defects in chromosome segregation. A significant overexpression of Aurora B has been found in a variety of human tumors including non-small cell lung carcinoma, astrocytoma, seminoma and carcinomas of the colon, prostate, endometrium and thyroid. The expression level of Aurora B is associated with cell proliferation and prognosis in these tumors.